The Discovery of Novel Anti-tumor Drugs
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 37
Special Issue Editor
Interests: cancer; metastasis; high-throughput screening; immune microenvironment; drug discovery; pharmacology of anti-neoplastic drugs
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The aim of the Special Issue is to attract high-quality papers focused on the activity and molecular mechanisms of action of novel antitumor molecules. We are especially interested in articles that seek to discover novel oncological targets based on biologic and genotypic contexts and further rationally design effective molecules to illustrate the relationship between chemical structure and biological activity. The potential anticancer inhibitors for the Special Issue include, but are not limited to, traditional chemotherapeutic agents, targeted therapies, and immunomodulators. Small molecules, antibody–drug conjugates, PROTACs, peptides, and polysaccharides are all eligible for the Special Issue. We welcome both original and review articles.
Dr. Peiju Qiu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antitumor molecules
- molecular mechanisms
- chemotherapeutic agents
- targeted therapies
- immunomodulators
